161 related articles for article (PubMed ID: 34967360)
1. Comparative efficacy and safety of antivascular endothelial growth factors for central retinal vein occlusion: A protocol for systematic review and network meta-analysis.
Liu Z; Wang S; Ma A; Zhao B
Medicine (Baltimore); 2021 Dec; 100(52):e28283. PubMed ID: 34967360
[TBL] [Abstract][Full Text] [Related]
2. Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion.
Braithwaite T; Nanji AA; Greenberg PB
Cochrane Database Syst Rev; 2010 Oct; (10):CD007325. PubMed ID: 20927757
[TBL] [Abstract][Full Text] [Related]
3. Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.
Hu Q; Li H; Xu W; Du Y; Ma C; He J
Indian J Ophthalmol; 2019 Nov; 67(11):1800-1809. PubMed ID: 31638037
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.
Gewaily D; Muthuswamy K; Greenberg PB
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD007324. PubMed ID: 26352007
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal Injection of Anti-Vascular Endothelial Growth Factors Combined with Corticosteroids for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis.
Namvar E; Yasemi M; Nowroozzadeh MH; Ahmadieh H
Semin Ophthalmol; 2024 Jan; 39(1):109-119. PubMed ID: 37621098
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and effectiveness of anti-VEGF or steroids monotherapy versus combination treatment for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.
Zhang W; Liu Y; Sang A
BMC Ophthalmol; 2022 Dec; 22(1):472. PubMed ID: 36474156
[TBL] [Abstract][Full Text] [Related]
7. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Mitry D; Bunce C; Charteris D
Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of bevacizumab, ranibizumab, and aflibercept for treatment of macular edema secondary to retinal vein occlusion: a systematic review and network meta-analysis.
Sangroongruangsri S; Ratanapakorn T; Wu O; Anothaisintawee T; Chaikledkaew U
Expert Rev Clin Pharmacol; 2018 Sep; 11(9):903-916. PubMed ID: 30071180
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of anti-vascular endothelial growth factor remedy for macular edema secondary to central retinal vein occlusion.
Huang P; Niu W; Ni Z; Wang R; Sun X
PLoS One; 2013; 8(12):e82454. PubMed ID: 24376538
[TBL] [Abstract][Full Text] [Related]
10. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Shalchi Z; Mahroo O; Bunce C; Mitry D
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
[TBL] [Abstract][Full Text] [Related]
11. Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis.
Zhou S; Gao J; Xu X
Clin Exp Ophthalmol; 2014; 42(7):637-49. PubMed ID: 24330277
[TBL] [Abstract][Full Text] [Related]
12. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
[TBL] [Abstract][Full Text] [Related]
13. Comparison between anti-VEGF therapy and corticosteroid or laser therapy for macular oedema secondary to retinal vein occlusion: A meta-analysis.
Qian T; Zhao M; Xu X
J Clin Pharm Ther; 2017 Oct; 42(5):519-529. PubMed ID: 28639290
[TBL] [Abstract][Full Text] [Related]
14. Acute Kidney Injury from Intravitreal Anti-vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Tsao YC; Chen TY; Wang LA; Lee CC; Lee WA; Hsu SM; Lai CC; Shao SC; Hung JH; Lai EC
BioDrugs; 2023 Nov; 37(6):843-854. PubMed ID: 37676536
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.
Gewaily D; Greenberg PB
Cochrane Database Syst Rev; 2009 Jan; (1):CD007324. PubMed ID: 19160332
[TBL] [Abstract][Full Text] [Related]
16. Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema: Clinical Outcomes in 130 247 Eyes.
Ciulla TA; Hussain RM; Taraborelli D; Pollack JS; Williams DF
Ophthalmol Retina; 2022 Sep; 6(9):796-806. PubMed ID: 35381391
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.
Hoeh AE; Ach T; Schaal KB; Scheuerle AF; Dithmar S
Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1635-41. PubMed ID: 19633982
[TBL] [Abstract][Full Text] [Related]
18. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
[TBL] [Abstract][Full Text] [Related]
19. Steroids and macular edema from retinal vein occlusion.
Glacet-Bernard A; Coscas G; Zourdani A; Soubrane G; Souied EH
Eur J Ophthalmol; 2011; 21 Suppl 6():S37-44. PubMed ID: 23264327
[TBL] [Abstract][Full Text] [Related]
20. The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications.
Papadia M; Misteli M; Jeannin B; Herbort CP
Int Ophthalmol; 2014 Dec; 34(6):1193-201. PubMed ID: 25245600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
